Keeping ahead of the resistance curve: product bundling to conserve artemisinin-based combination therapy.
Chatham House Centre on Global Health Security, Royal Institute of International Affairs, London, UK; Public Health Strategy Division, Public Health England, London, UK.
Osman A
OA
Dar
King's Sierra Leone Partnership, Freetown, Sierra Leone; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Sakib
S
Rokadiya
Chatham House Centre on Global Health Security, Royal Institute of International Affairs, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. Electronic address: david.heymann@lshtm.ac.uk.
David L
DL
Heymann
D000962:Antimalarials / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use*; D006801:Humans; D016778:Malaria, Falciparum / Q000175:diagnosis* / Q000188:drug therapy; D008403:Mass Screening
D000962:Antimalarials; D037621:Artemisinins; C031327:artemisinin